The U.S. Federal Trade Commission has cleared medical transcription services provider MedQuist Holdings' acquisition of M*Modal, a speech recognition software developer.
FTC OKs MedQuist, M*Modal deal
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.